Physio 15 Poor funding for physio research hampers attempts to build evidence base The
Rob De Bie (Principal Investigator), Prof. PhD Full Professor, Neurology (AMC) Full Professor, Amsterdam Neuroscience - Neurodegeneration (AMC) Full Professor, APH - Aging & Later Life (AMC) https://orcid.org/0000-0001-5267-0784 1997. 2023 Research activity per year Overview Network Projects (3) Research output (212) Prizes (1) Supervised Work (3)
Rob de Bie LinkedIn
Rob de Bie is a neurologist and works at the Academic Medical Center in Amsterdam. In 2005-06, he did a Movement Disorders Fellowship with Prof Tony Lang in Toronto. His research focuses on the treatment of Parkinson's disease, including the current NSTAPS study.
AMLnZu68HAg6WOdHloGSOPE3NkBHQ1i5pMYYr7Y8QWE=s900ckc0x00ffffffnorj
Rob A de Bie currently works at the CAPHRI School for Public Health and Primary Care, Maastricht University. Rob does research in Musculoskeletal Disorders, etiology, prognosis and impact of.
Karakteristieken voetbal regio Deventer / Zutphen Foto destentor.nl
DATA SYNTHESIS: We assessed bias using the Cochrane Risk-of-Bias tool (ROB 2.0) and therapeutic validity using the i-CONTENT tool. Standardized mean differences (Hedges' g) and 95% confidence intervals (CIs) were calculated for knee functioning.
Wie is wie INfusie VErsus STimulatie
Berid Rackwitz, Rob de Bie, Heribert Limm, Katharina von Garnier, Thomas Ewert, and Gerold Stucki. Clinical Rehabilitation 2006 20: 7, 553-567 Download Citation. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below.
Rob de Bie Hospital Patient Monitoring Manager BeNeLux Philips LinkedIn
De Bie has worked as a neurologist at the AMC since 2006. In 2005 and 2006, he took a clinical fellowship in movement disorders at Toronto Western Hospital in Canada. He leads the movement disorders group at the AMC and the Neurodegeneration programme at the Netherlands Institute for Neuroscience in Amsterdam.
Anticiperen of acuut reageren de toekomst van intensive care Philips
a RoB 2.0: D1, randomization process; D2, deviations from the intended interventions; D3, missing outcome data; D4. analysis, and writing of the draft. At the end, they took care of the visualization of the manuscript. Dr Lenssen, Dr de Bie, Dr Scherr, and Dr Swanenburg were involved in reviewing and editing the writing part of the.
Rob de Bie Autoschade WStyle
Rob de Bie Prof. PhD Full Professor, ANS - Neurodegeneration Full Professor, APH - Aging & Later Life Full Professor, Neurology PI 1997 2023 Specialization Neurology, Movement Disorders Focus of research Improving treatment of Movement Disorders.
two men standing next to each other in front of a train on the tracks and buildings
Rob de Bie studied physiotherapy (graduated 1987, Deventer), human movement sciences (graduated in 1991, Maastricht University) and epidemiology (registered in 1992), obtained his PhD in 1998 and has been Associate Professor in Clinical Epidemiology at Maastricht University, the Netherlands from 1999 -2003.
Rob de Bie (RobAdeBie) Twitter
Study design: A systematic review of randomized controlled trials. Objectives: To evaluate the effectiveness of segmental stabilizing exercises for acute, subacute and chronic low back pain with regard to pain, recurrence of pain, disability and return to work.
AL5GRJXTy3XnyKqU3GwkFM3wRCkzwPKwqkmlUIHs71JY=s900ckc0x00ffffffnorj
Rob de Bie studied physiotherapy (graduated 1987, Deventer), human movement sciences (graduated in 1991, Maastricht University) and epidemiology (registered in 1992), obtained his PhD in 1998 and has been Associate Professor in Clinical Epidemiology at Maastricht University, the Netherlands from 1999 -2003.
Rob de Mol van Raaijmakers & de Mol Advies
Until more effective methods of providing stable dopamine concentrations are developed, current evidence supports the use of levodopa as initial symptomatic treatment in most patients with Parkinson's disease, starting with low doses and titrating to therapeutic threshold.
Rob de Leeuw Perfon
Rob A de Bie currently works at the CAPHRI School for Public Health and Primary Care, Maastricht University. Rob does research in Musculoskeletal Disorders, etiology, prognosis and impact of.
Rob de Bie, hoogleraar Neurologische Bewegingsstoornissen Universiteit van Amsterdam
Rob de Bie received financial support for a fellowship program from Medtronic, and has received research grants from ZonMw, Internationaal Parkinson Fonds, Prinses Beatrix Fonds, Michael J Fox Foundation, and Parkinson Vereniging. Günther Deuschl has received lecture fees from Orion, Lundbeck, Teva and Pfizer and has been serving as a.
Parkinson Geef aan onderzoek naar behandeling op maat ProPark (BS051) LUMC Campagne
Rob de Bie focust zich vooral op het verbeteren van de behandeling van Parkinson. Hieronder valt de behandeling met diepe hersenstimulatie, die in het AMC ook bij mensen met andere bewegingsstoornissen wordt toegepast. De Bie heeft diverse grote klinische onderzoeken geïnitieerd en geleid die hebben bijgedragen aan de verbetering van de.
Lezing '100 Jaar Radio Omroep' Omroep Zender Museum
Rob M A de Bie Academisch Medisch Centrum Universiteit van Amsterdam | AMC · Department of Neurology MD, PhD Connect with experts in your field Join ResearchGate to contact this researcher.